Skip to main content

Advertisement

SpringerLink
Log in

Photosensitizers and light sources for photodynamic therapy of the Bowen’s disease

  • Mini Review
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Bowen’s disease is a neoplastic skin disease, known as squamous cell carcinoma in situ. The treatment options for Bowen’s disease are: cryotherapy, curettage, surgery, topical therapy and radiotherapy. In the past recent years, photodynamic therapy was used as a new treatment method. The purpose of this paper is to summarize the results of clinical and research studies with respect to the photodynamic therapy of Bowen’s disease. A search of three databases was conducted using specific keywords and explicit inclusion and exclusion criteria for the study of photosensitizers, light sources and their efficacy in photodynamic therapy of Bowen’s disease. Two photosensitizers have been used mainly for photodynamic therapy of Bowen’s disease therapy: δ-aminolevulinic acid and methyl aminolevulinate. These photosensitizers have been activated with both coherent (lasers) and non-coherent (lamps and LEDs) light sources. Fluence has been set in a large domain (10–240 J/cm2) and irradiance was 0.23–100 mW/cm2. All these light sources have the same efficacy. The high response rates were obtained using methyl aminolevulinate and light emitting diode as light source. These results have demonstrated that photodynamic therapy using methyl aminolevulinate as photosensitizer could be considered as one of the first therapeutic options for Bowen’ disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Attili SK, Lesar A, McNeill A, Camacho-Lopez M, Moseley H, Ibbotson S, Samuel IDW, Ferguson J (2009) An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer. Br J Dermatol 161(1):170–173. doi:10.1111/j.1365-2133.2009.09096.x

    Google Scholar 

  2. Britton JE, Goulden V, Stables G et al (2005) Investigation of the use of the pulsed dye laser in the treatment of Bowen’s disease using 5-aminolaevulinic acid phototherapy. Br J Dermatol 153(4):780–784

    Article  PubMed  CAS  Google Scholar 

  3. Calzavara-Pinton PG, Venturini M, Sala R et al (2008) Methylaminolaevulinate-based photodynamic therapy of Bowen’s disease and squamous cell carcinoma. Br J Dermatol 159(1):137–144

    Article  PubMed  CAS  Google Scholar 

  4. Clark C, Bryden A, Dawe R et al (2003) Topical 5-aminolaevulinic acid photodynamic therapy for cutaneous lesions: outcome and comparison of light sources. Photodermatol Photoimmunol Photomed 19(3):134–141

    Article  PubMed  CAS  Google Scholar 

  5. Cox NH, Eedy DJ, Morton CA (1999) Guidelines for management of Bowen’s disease. Br J Dermatol 141:633–641

    Article  PubMed  CAS  Google Scholar 

  6. Doffoel-Hantz V, Sparsa A, Marin B et al (2008) The value of photodynamic therapy in the treatment of Bowen’s disease. Ann Dermatol Venereol 135(12):822–827

    Article  PubMed  CAS  Google Scholar 

  7. Dougherty TJ (1987) Photosensitizers: therapy and detection of malignant tumors. Photochem Photobiol 45:879–889

    Article  PubMed  CAS  Google Scholar 

  8. Fantini F, Greco A, Cesinaro AM et al (2008) Pathologic changes after photodynamic therapy for basal cell carcinoma and Bowen disease. Arch Dermatol 144(2):186–194

    Article  PubMed  Google Scholar 

  9. Fritsch C, Verwohlt B, Bolsen K, Ruzicka T, Goerz G (1996) Influence of topical photodynamic therapy with 5-aminolevulinic acid on porphyrin metabolism. Arch Dermatol Res 288(9):517–521

    Article  PubMed  CAS  Google Scholar 

  10. Haas ER, de Vijlder HC, Sterenborg HJ et al (2009) Fractionated aminolevulinic acid–photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer. J Eur Acad Dermatol Venereol 23(5):571–572

    Article  Google Scholar 

  11. Haddad R, Nesher E, Weiss J et al (2004) Photodynamic therapy for Bowen’s disease and squamous cell carcinoma of the skin. Photodiagn Photodyn Ther 1(3):225–230

    Article  CAS  Google Scholar 

  12. Holt PJ (1988) Cryotherapy for skin cancer: results over a 5-year period using liquid nitrogen spray cryosurgery. Br J Dermatol 119:231–240

    Article  PubMed  CAS  Google Scholar 

  13. Kim YJ, Kang HY, Lee ES, Kim YC (2007) Photodynamic therapy for treatment of Bowen’s disease. Korean J Dermatol 45(3):237–241. http://koreamed.org/SearchBasic.php?RID=0048KJD%2F2007.45.3.237&DT=1&QY=%22Korean+J+Dermatol%22+%5BJTI%5D++AND+2007+%5BDPY%5D+AND+Mar+%5BDPM%5D

    Google Scholar 

  14. Lehmann P (2007) Methyl aminolaevulinate–photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol 156(5):793–801

    Article  PubMed  CAS  Google Scholar 

  15. Mackenzie-Wood A, Kossard S, de Launey J et al (2001) Imiquimod 5% cream in the treatment of Bowen’s disease. J Am Acad Dermatol 44:462–470

    Article  PubMed  CAS  Google Scholar 

  16. Morton CA (2007) Methyl aminolevulinate: actinic keratoses and Bowen’s disease. Dermatol Clin 25(1):81–87

    Article  PubMed  CAS  Google Scholar 

  17. Morton CA, Whitehurst C, McColl JH et al (2001) Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma. Arch Dermatol 137(3):319–324

    PubMed  CAS  Google Scholar 

  18. Morton CA, Whitehurst C, Moore JV, MacKie RM (2000) Comparison of red and green light in the treatment of Bowen’s disease by photodynamic therapy. Br J Dermatol 143(4):699–700

    Article  Google Scholar 

  19. Morton CA, Whitehurst C, Moseley H et al (1995) Development of an alternative light source to lasers for photodynamic therapy: 3. Clinical evaluation in the treatment of pre-malignant non-melanoma skin cancer. Lasers Med Sci 10(3):165–171

    Article  Google Scholar 

  20. Parlette EC (2004) Red light laser photodynamic therapy of Bowen’s disease. J Drugs Dermatol 3:S22–S24. http://findarticles.com/p/articles/mi_m0PDG/is_6_3/ai_n12418329/

    Google Scholar 

  21. Patel G, Goodwin R, Chawla M et al (2006) Imiquimod 5% cream monotherapy for cutaneous squamous cell carcinoma in situ (Bowen’s disease): a randomized, double-blind, placebo-controlled trial. J Am Acad Dermatol 54:1025–1032

    Article  PubMed  Google Scholar 

  22. Puizina-Ivic N, Zorc H, Vanjaka-Rogosic L, Miric L, Persin A (2008) Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy. Coll Antropol 32(Suppl 2):67–73. http://www.ncbi.nlm.nih.gov/pubmed/19138010

    Google Scholar 

  23. Salim A, Leman JA, Mccoll JH et al (2003) Randomized comparison of photodynamic therapy with topical 5-fluorouracil in Bowen’s disease. Br J Dermatol 148(3):539–543

    Article  PubMed  CAS  Google Scholar 

  24. Soga F, Hanada K, Ueda E et al (2005) Photodynamic therapy using topical 5-aminolevulinic acid for Bowen’s disease. Rinsho Derma 47(7):923–927. http://sciencelinks.jp/j-east/article/200521/000020052105A0676130.php

    Google Scholar 

  25. Stone N, Burge S (1999) Bowen’s disease of the leg treated with weekly pulses of 5% fluorouracil cream. Br J Dermatol 140:987–988

    Article  PubMed  CAS  Google Scholar 

  26. Tan B, Sinclair R, Foley P (2004) Photodynamic therapy for subungual Bowen’s disease. Australas J Dermatol 45(3):172–174

    Article  PubMed  Google Scholar 

  27. Thestrup-Pedersen K, Ravnborg L, Reymann F (1988) Morbus Bowen. Acta Derm Venereol 68:236–239

    PubMed  CAS  Google Scholar 

  28. Tualle JM, Gelebart B, Tinet E et al (1996) Real time optical coefficient evaluation from time and space resolved measurements in biological tissues. Opt Commun 124:216–221

    Article  CAS  Google Scholar 

  29. Varma S, Wilson H, Kurwa HA et al (2001) Bowen’s disease, solar keratoses and superficial basal cell carcinomas treated by photodynamic therapy using a large-field incoherent light source. Br J Dermatol 144(3):567–574

    Article  PubMed  CAS  Google Scholar 

  30. Wong TW, Sheu HM, Lee JY, Fletcher RJ (2001) Photodynamic therapy for Bowen’s disease (squamous cell carcinoma in situ) of the digit. Dermatol Surg 27(5):452–456

    Article  PubMed  CAS  Google Scholar 

  31. Xu S, Wang X, Xu W et al (2002) Evaluation of photodynamic therapy of skin cancers with δ-aminolevulinic acid. Chin Med J 115(8):1141–1145

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by The Ministry of Education, Research and Youth by the PN II Program, Grant No. 62074/2008.

Author information

Authors and Affiliations

  1. National Institute of Research and Development for Optoelectronics INOE 2000, PO Box MG5, 409 Atomistilor street, Magurele, 077125, Ilfov, Romania

    M. A. Calin, D. Savastru & M. Tautan

  2. Department of Dermatology, Grigore Alexandrescu Hospital, 30-32, Iancu De Hunedoara street, Bucharest, Romania

    A. Diaconeasa

Authors
  1. M. A. Calin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Diaconeasa
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D. Savastru
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Tautan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. A. Calin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Calin, M.A., Diaconeasa, A., Savastru, D. et al. Photosensitizers and light sources for photodynamic therapy of the Bowen’s disease. Arch Dermatol Res 303, 145–151 (2011). https://doi.org/10.1007/s00403-011-1122-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00403-011-1122-3

Keywords

Search

Navigation